Pacer Advisors Inc. Sells 30,999 Shares of GE HealthCare Technologies Inc. $GEHC

Pacer Advisors Inc. decreased its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report) by 44.8% in the first quarter, Holdings Channel reports. The fund owned 38,183 shares of the company’s stock after selling 30,999 shares during the period. Pacer Advisors Inc.’s holdings in GE HealthCare Technologies were worth $2,718,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently bought and sold shares of the company. Laurel Wealth Advisors LLC acquired a new stake in shares of GE HealthCare Technologies in the fourth quarter valued at about $26,000. Optima Capital LLC bought a new position in shares of GE HealthCare Technologies in the fourth quarter worth about $27,000. Godfrey Financial Associates Inc. acquired a new position in shares of GE HealthCare Technologies during the 4th quarter worth about $27,000. Montag A & Associates Inc. lifted its position in shares of GE HealthCare Technologies by 105.4% during the 4th quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock worth $28,000 after purchasing an additional 175 shares during the last quarter. Finally, Transamerica Financial Advisors LLC boosted its stake in GE HealthCare Technologies by 331.6% during the 4th quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock valued at $28,000 after purchasing an additional 262 shares during the period. 82.06% of the stock is currently owned by institutional investors.

Insider Buying and Selling at GE HealthCare Technologies

In other GE HealthCare Technologies news, Director Rodney F. Hochman purchased 1,618 shares of the stock in a transaction on Tuesday, May 12th. The shares were purchased at an average price of $62.03 per share, with a total value of $100,364.54. Following the acquisition, the director directly owned 1,618 shares of the company’s stock, valued at $100,364.54. This represents a ∞ increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Kevin Lobo acquired 10,000 shares of the company’s stock in a transaction dated Friday, May 22nd. The stock was acquired at an average price of $64.18 per share, with a total value of $641,800.00. Following the purchase, the director owned 14,363 shares in the company, valued at approximately $921,817.34. This represents a 229.20% increase in their position. The SEC filing for this purchase provides additional information. 0.36% of the stock is owned by company insiders.

GE HealthCare Technologies Stock Up 2.1%

GEHC stock opened at $71.77 on Friday. GE HealthCare Technologies Inc. has a twelve month low of $58.75 and a twelve month high of $89.77. The company has a quick ratio of 0.97, a current ratio of 1.26 and a debt-to-equity ratio of 0.92. The company has a market cap of $32.42 billion, a PE ratio of 16.46, a price-to-earnings-growth ratio of 2.03 and a beta of 0.69. The business’s 50-day simple moving average is $64.72 and its 200 day simple moving average is $70.07.

GE HealthCare Technologies (NASDAQ:GEHCGet Free Report) last posted its quarterly earnings results on Wednesday, July 29th. The company reported $1.13 EPS for the quarter, beating the consensus estimate of $1.04 by $0.09. GE HealthCare Technologies had a return on equity of 20.12% and a net margin of 9.33%.The firm had revenue of $5.29 billion during the quarter, compared to analysts’ expectations of $5.26 billion. During the same quarter in the prior year, the firm posted $1.06 EPS. The company’s revenue for the quarter was up 5.8% on a year-over-year basis. On average, research analysts anticipate that GE HealthCare Technologies Inc. will post 4.93 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Friday, July 24th will be paid a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Friday, July 24th. GE HealthCare Technologies’s dividend payout ratio is presently 3.21%.

Analyst Ratings Changes

A number of research firms have issued reports on GEHC. Barclays lowered their target price on GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating on the stock in a report on Thursday, April 30th. BNP Paribas Exane cut their price target on GE HealthCare Technologies from $95.00 to $88.00 in a report on Friday, May 1st. Hovde Group began coverage on GE HealthCare Technologies in a research report on Friday, July 17th. They issued a “market perform” rating and a $14.00 price objective for the company. Weiss Ratings downgraded shares of GE HealthCare Technologies from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, May 15th. Finally, Mizuho dropped their target price on shares of GE HealthCare Technologies from $90.00 to $80.00 in a research report on Thursday, April 30th. Ten investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, GE HealthCare Technologies has a consensus rating of “Hold” and a consensus target price of $77.73.

View Our Latest Stock Report on GE HealthCare Technologies

About GE HealthCare Technologies

(Free Report)

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.

Read More

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report).

Institutional Ownership by Quarter for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.